{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:29Z","timestamp":1753890929991,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00246","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T13:43:55Z","timestamp":1518529435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Levels of Migration Inhibitory Factor (MIF) and In Situ Expression of MIF and Its Receptor CD74 in Lepromatous Leprosy Patients: A Preliminary Report"],"prefix":"10.3389","volume":"9","author":[{"given":"Marco Alonso","family":"Martinez-Guzman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabell","family":"Alvarado-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidal","family":"Delgado-Rizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Garcia-Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Arturo","family":"Mayorga-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Laura","family":"Pereira-Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Fafutis-Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1590\/abd1806-4841.20142450","article-title":"Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects \u2013 part 1","volume":"89","author":"Last\u00f3ria","year":"2014","journal-title":"An Bras Dermatol"},{"key":"B2","unstructured":"Weekly Epidemiological Record Relev\u00e9 \u00c9pid\u00e9miologique Hebdomadaire2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.actatropica.2016.01.008","article-title":"In situ expression of M2 macrophage subpopulation in leprosy skin lesions","volume":"157","author":"de Sousa","year":"2016","journal-title":"Acta Trop"},{"key":"B4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clindermatol.2014.10.003","article-title":"Histopathology of the lepromatous skin biopsy","volume":"33","author":"Massone","year":"2015","journal-title":"Clin Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0004335","DOI":"10.1371\/journal.pntd.0004335","article-title":"Mycobacterium leprae-infected macrophages preferentially primed regulatory T cell responses and was associated with lepromatous leprosy","volume":"10","author":"Yang","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fimmu.2013.00115","article-title":"Arrest functions of the MIF ligand\/receptor axes in atherogenesis","volume":"4","author":"Tillmann","year":"2013","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1172\/JCI200316288.Introduction","article-title":"Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor","volume":"111","author":"Ashcroft","year":"2003","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1365-2133.1999.03206.x","article-title":"Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease","volume":"141","author":"Steinhoff","year":"1999","journal-title":"Br J Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74","volume":"197","author":"Leng","year":"2003","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbamcr.2016.03.026","article-title":"The multifaceted roles of the invariant chain CD74 \u2013 more than just a chaperone","volume":"1863","author":"Schr\u00f6der","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B12","doi-asserted-by":"publisher","first-page":"E2997","DOI":"10.1073\/pnas.1301128110","article-title":"Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis","volume":"110","author":"Das","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B13","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.4049\/jimmunol.161.5.2383","article-title":"Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-a","volume":"161","author":"Juttner","year":"1998","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.humimm.2016.07.006","article-title":"Association between STR -794 CATT5-8 and SNP -173 G\/C polymorphisms in the MIF gene and lepromatous leprosy in mestizo patients of western Mexico","volume":"77","author":"Martinez-Guzman","year":"2016","journal-title":"Hum. Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0118391","DOI":"10.1371\/journal.pone.0118391","article-title":"Human papillomavirus infection correlates with inflammatory stat3 signaling activity and IL-17 level in patients with colorectal cancer","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of helsinki. Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"J Am Med Assoc"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL","article-title":"Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum","author":"Bansal","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/jclinpath-2016-204110","article-title":"Th9 cytokines response and its possible implications in the immunopathogenesis of leprosy","volume":"70","author":"de Sousa","year":"2016","journal-title":"J. Clin. Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/365756a0","article-title":"MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia","volume":"365","author":"Bernhagen","year":"1993","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S385","DOI":"10.1086\/374752","article-title":"Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis","volume":"187","author":"Calandra","year":"2003","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.metabol.2015.09.007","article-title":"Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes","volume":"64","author":"Liang","year":"2015","journal-title":"Metabolism"},{"key":"B22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1096\/fj.201600860R","article-title":"Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin","volume":"31","author":"Brocks","year":"2017","journal-title":"FASEB J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/ijd.13344","article-title":"Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata","volume":"55","author":"Salem","year":"2016","journal-title":"Int J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1096\/fj.201500189R","article-title":"Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence","volume":"30","author":"Holowka","year":"2016","journal-title":"FASEB J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1128\/IAI.70.9.5167-5176.2002","article-title":"Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function","volume":"70","author":"Hashimoto","year":"2002","journal-title":"Infect Immun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.4049\/jimmunol.179.12.8128","article-title":"LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells","volume":"179","author":"Lee","year":"2007","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1365-3083.2009.02301.x","article-title":"MHC II and the endocytic pathway: regulation by invariant chain","volume":"70","author":"Landsverk","year":"2009","journal-title":"Scand J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/abd1806-4841.20132050","article-title":"Indeterminate leprosy and lepromatous index case: four cases in the same family","volume":"88","author":"Priscilla","year":"2013","journal-title":"An Bras Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00246\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T23:43:04Z","timestamp":1693525384000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00246\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2018.00246"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00246","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"article-number":"246"}}